Results of a dose-finding phase 1b study of subcutaneous atezolizumab in patients with locally advanced or metastatic Non–Small cell lung cancer

by on 19 d'abril de 2021 with No hi ha comentaris
  • Felip, E., Burotto, M., Zvirbule, Z., Herraez-Baranda, L. A., Chanu, P., Kshirsagar, S., . . . Restuccia, E. (2021). Results of a dose-finding phase 1b study of subcutaneous atezolizumab in patients with locally advanced or metastatic Non–Small cell lung cancer. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.936 (Article en premsa)

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *